Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2022-07-06 00:00:00 ET · period of report 2022-06-30 · accession 0001104659-22-077799 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-06 | 2022-06-30 | RYTM | Smith Hunter C | CFO | M - OptEx | — | +25.0K | 65.2K | +62% | — |
| D | 2022-07-06 | 2022-07-01 | RYTM | Smith Hunter C | CFO | S - Sale+OE | $4.08 | -7,547 | 57.6K | -12% | -$30.8K |
| D | 2022-07-06 | 2022-06-30 | RYTM | Smith Hunter C | CFO | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-30 | M | A | 25,000 | — | 65,161 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Common | Common Stock | 2022-07-01 | S | D | 7,547 | $4.08 | 57,614 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-06-30 | M | D | 25,000 | $0.00 | 0 | D | — · — to — | 25,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) On June 30, 2020, the Reporting Person was granted 25,000 restricted stock units, which vested in full on June 30, 2022. The restricted stock units have no expiration date. |